Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-lab... by Vano, Yann-Alexandre, MD, Elaidi, Réza, PhD, Bennamoun, Mostefa, MD, Chevreau, Christine, Prof, Borchiellini, Delphine, MD, Pannier, Diane, MD, Maillet, Denis, MD, Gross-Goupil, Marine, MD, Tournigand, Christophe, Prof, Laguerre, Brigitte, MD, Barthélémy, Philippe, MD, Coquan, Elodie, MD, Gravis, Gwenaëlle, Prof, Houede, Nadine, Prof, Cancel, Mathilde, MD, Huillard, Olivier, MD, Beuzeboc, Philippe, MD, Fournier, Laure, Prof, Méjean, Arnaud, Prof, Cathelineau, Xavier, Prof, Doumerc, Nicolas, MD, Paparel, Philippe, Prof, Bernhard, Jean-Christophe, Prof, de la Taille, Alexandre, Prof, Bensalah, Karim, Prof, Tricard, Thibault, MD, Waeckel, Thibaut, MD, Pignot, Géraldine, MD, Braychenko, Elena, MD, Caruso, Stefano, PhD, Sun, Cheng-Ming, PhD, Verkarre, Virginie, MD, Lacroix, Guillaume, MSc, Moreira, Marco, Meylan, Maxime, PhD, Bougouïn, Antoine, Phan, Letuan, MSc, Thibault-Carpentier, Christelle, PhD, Zucman-Rossi, Jessica, Prof, Fridman, Wolf Herman, Prof, Sautès-Fridman, Catherine, Prof, Oudard, Stéphane, Prof

Get full text

A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies by Rini, Brian, Prof, Goddard, Audrey, PhD, Knezevic, Dejan, PhD, Maddala, Tara, PhD, Zhou, Ming, MD, Aydin, Hakan, MD, Campbell, Steven, MD, Elson, Paul, PhD, Koscielny, Serge, PhD, Lopatin, Margarita, MS, Svedman, Christer, MD, Martini, Jean-Francois, PhD, Williams, J Andrew, PhD, Verkarre, Virginie, MD, Radulescu, Camelia, MD, Neuzillet, Yann, MD, Hemmerlé, Isabelle, BS, Timsit, Marc Olivier, MD, Tsiatis, Athanasios C, MD, Bonham, Michael, MD, Lebret, Thierry, Prof, Mejean, Arnaud, Prof, Escudier, Bernard, MD

Get full text